Related Experiment Video
Updated: Jun 4, 2025
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications
Ryan Osgueritchian1, Hoda Mombeini1, Vivek P Jani1
1Johns Hopkins University Division of Cardiology, Baltimore, MD, USA.
Insights
Systemic sclerosis (SSc)-associated myocardial disease is a serious complication. Early detection using advanced imaging and biomarkers improves outcomes by identifying high-risk patients.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic sclerosis (SSc) frequently involves the heart, leading to significant morbidity and mortality.
- Cardiac involvement in SSc is driven by inflammation, microvascular dysfunction, and fibrosis.
- Understanding these mechanisms is crucial for managing SSc-associated myocardial disease.
Purpose of the Study:
- To review the mechanisms of SSc-associated myocardial disease.
- To identify critical risk factors for cardiac involvement in SSc.
- To explore advanced diagnostic tools for early detection and risk stratification.
Main Methods:
- Review of recent literature on SSc-associated myocardial disease.
- Analysis of risk factors including autoantibody profiles, disease duration, and comorbidities.
- Evaluation of advanced imaging techniques and biomarkers for early diagnosis.
Main Results:
- Specific autoantibody profiles, disease duration, and comorbidities are key risk factors.
- Advanced imaging and biomarkers aid in early identification and risk stratification.
- Subclinical myocardial involvement can be detected, potentially preventing symptomatic disease progression.
Conclusions:
- SSc-associated myocardial disease is challenging to predict.
- Novel imaging and biomarker strategies offer promising avenues for early diagnosis and intervention.
- Integrating advanced approaches can enhance screening, mitigate progression, and improve patient outcomes.
Purpose Of Review:
The present review aims to address systemic sclerosis (SSc)-associated myocardial disease, a significant cause of morbidity and mortality, by examining the mechanisms of inflammation, microvascular dysfunction, and fibrosis that drive cardiac involvement. The objective is to elucidate critical risk factors and explore advanced diagnostic tools for early detection, enhancing patient outcomes by identifying those at highest risk.
Recent Findings:
Recent studies underscore the importance of specific autoantibody profiles, disease duration, and cardiovascular comorbidities as key risk factors for severe cardiac manifestations in SSc. Additionally, advanced imaging techniques and biomarker analyses have emerged as pivotal tools for early identification and risk stratification. These innovations enable clinicians to detect subclinical myocardial involvement, potentially averting progression to symptomatic disease. SSc-associated myocardial disease remains challenging to predict, yet novel imaging modalities and biomarker-guided strategies offer a promising pathway for early diagnosis and targeted intervention. Integrating these approaches may enable more effective early detection and screening strategies as well as mitigation of disease progression, ultimately enhancing clinical outcomes for patients with SSc at-risk for adverse clinical outcomes.
Related Concept Videos
01:17Pathophysiology of Heart Failure
01:20Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...